<DOC>
	<DOCNO>NCT01479894</DOCNO>
	<brief_summary>This retrospective genetic analysis store tumor tissue sample evaluate distribution Recurrence Score® gene group stage II colon cancer African American ( AA ) Caucasian individual . Other covariant factor medical chart analyze well . Three institution contribute patient study total patient number goal approximately 200 approximately 100 AA approximately 100 Caucasian . As enrollment study proceeds Caucasian subject match every African American enrol .</brief_summary>
	<brief_title>Genetic Analysis Evaluate Racial Difference Outcome Patients With Colon Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colonic Neoplasms</mesh_term>
	<criteria>Subjects must 18 year age old . Subjects must AA Caucasian . Subjects pathologic stage II colon cancer ; Irrespective number node examine . Patients race AA Caucasian . No tumor block available initial diagnosis . No tumor little tumor ( &lt; 5 % tumor present ) block assess examination H &amp; E slide Genomic Health , Inc ( GHI ) designate pathologist . Tumor type adenocarcinoma NOS ( otherwise specify ) mucinous carcinoma assess examination H &amp; E slide GHIdesignated pathologist . Insufficient RNA ( &lt; 5 ng/μL 300 ng ) RTPCR ( radiation therapy pathologic complete response ) analysis . Failure assay meet prespecified quality control ( QC ) specification .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>